Published in Diseases on January 22, 2016
Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet (2013) 4.61
The epidemiology of renal cell carcinoma. Eur Urol (2011) 3.85
Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J (1999) 3.70
A comprehensive urinary metabolomic approach for identifying kidney cancerr. Anal Biochem (2007) 3.14
Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res (2005) 2.67
Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol (2008) 2.37
Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A (2001) 2.22
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med (2009) 2.12
Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol Cancer (2006) 1.78
Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem (2004) 1.74
Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res (2006) 1.49
Urinary metabonomic study on colorectal cancer. J Proteome Res (2010) 1.44
The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem (2010) 1.43
NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem Res Toxicol (2003) 1.42
Renal cell carcinoma: management of advanced disease. J Urol (1999) 1.31
Metabolic profiling reveals key metabolic features of renal cell carcinoma. J Cell Mol Med (2011) 1.23
Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res (2012) 1.21
Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer (2008) 1.16
Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis. Anal Chim Acta (2008) 1.14
Molecular markers for predicting prognosis of renal cell carcinoma. Urol Oncol (2007) 1.05
Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum. MAGMA (2006) 1.04
Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. Anal Biochem (2001) 1.03
Quantification of creatinine kinetic parameters in patients with acute renal failure. Kidney Int (1998) 1.02
(1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool. J Proteome Res (2010) 1.01
Kinetic and structural features of betaine aldehyde dehydrogenases: mechanistic and regulatory implications. Arch Biochem Biophys (2009) 1.00
Regulation of glucose transport, and glucose transporters expression and trafficking in the heart: studies in cardiac myocytes. Am J Cardiol (1997) 0.99
In sickness and in health: the widespread application of creatine supplementation. Amino Acids (2011) 0.97
Effect of intestinal microflora on the urinary metabolic profile of rats: a (1)H-nuclear magnetic resonance spectroscopy study. Xenobiotica (2002) 0.95
Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis. Arthritis Res Ther (2011) 0.93
Current insights in renal cell cancer pathology. Urol Oncol (2007) 0.91
Evaluation of tubulointerstitial lesions' severity in patients with glomerulonephritides: an NMR-based metabonomic study. J Proteome Res (2007) 0.91
Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res (2001) 0.91
Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges. Ther Drug Monit (2008) 0.90
CTR2 identifies a population of cancer cells with stem cell-like features in patients with clear cell renal cell carcinoma. J Urol (2014) 0.88
ADAM17 promotes proliferation of collecting duct kidney epithelial cells through ERK activation and increased glycolysis in polycystic kidney disease. Am J Physiol Renal Physiol (2014) 0.85
Prognostic factors for renal cell carcinoma. Cancer Treat Rev (2008) 0.81
Strategy for NMR metabolomic analysis of urine in mouse models of obesity--from sample collection to interpretation of acquired data. J Pharm Biomed Anal (2015) 0.79
Variability of kidney tubular interstitial distortions in glomerulonephritis as measured by 1H-NMR urinalysis. Clin Chim Acta (1993) 0.78